4//SEC Filing
GRAYZEL DAVID S. 4
Accession 0001193125-25-251983
CIK 0001661998other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 9:17 PM ET
Size
5.9 KB
Accession
0001193125-25-251983
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
GRAYZEL DAVID S.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-10-23+53,521→ 53,521 totalExercise: $2.80Exp: 2035-10-22→ Common Stock (53,521 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) October 23, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.
- [F2]This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Q32 Bio Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001732786
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 9:17 PM ET
- Size
- 5.9 KB